Logo

Bio-Matrix Signs Letter of Intent with Vibragene

Apr 03, 2008
NEW YORK (GenomeWeb News) – Bio-Matrix Scientific Group has signed a letter of intent with the genetic analysis and anti-aging specialty company Vibragene, under which it will negotiate an agreement to supply genetic testing for certain disease biomarkers.
 
Bio-Matrix said that Vibragene expects to send it 100,000 specimens during the next 12 months. The firm also said that the addition of the DNA testing capabilities complements its current business lines of processing and storing stem cells for future medical use.
 
The agreement between the two companies will depend upon a number of conditions, including establishing an acceptable price.

Breaking News
The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.